© 1993 Oxford University Press
RESEARCH-ARTICLE |
Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndrome
1Department of Pathology Baltimore, MD 21205, USA 2Howard Hughes Medical Institute Baltimore, MD 21205, USA 3Department of Genetics Baltimore, MD 21205, USA 4Department of Pediatrics, Stanford University Stanford, CA 94305, USA 5Department of Pediatrics, The Johns Hopkins University School of Medicine Baltimore, MD 21205, USA
*To whom correspondence should be addressed
Received October 20, 1993; Accepted October 22, 1993
Dermal fibroblasts from nine Marfan syndrome patients with missense mutations in the fibrillin–1 gene (FBN1) produced nearly normal amounts of fibrillin as determined by quantitative pulse–chase experiments. However, six of the seven mutations involving substitutions of highly conserved cysteine residues exhibited lower rates of intracellular transport and secretion. This effect is likely due to improper folding, since intracellular fibrillin processing was also affected by the reducing agent dithiothreitol. Normal secretion patterns were seen in three mutations that either change the conformation of EGF–like domains or change consensus amino acids required for Ca+ +-binding. In all nine fibroblast strains, however, the deposition of fibrillin in the extracellular matrix was reduced to 50% of normal in two and to less than 30% in seven of the nine samples studied. The protein alterations caused by these missense mutations are associated with moderate to severe features of Marfan syndrome and a dominant negative mechanism is suggested to play a major role in their pathogenesis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P N Robinson, E Arteaga-Solis, C Baldock, G Collod-Beroud, P Booms, A De Paepe, H C Dietz, G Guo, P A Handford, D P Judge, et al. The molecular genetics of Marfan syndrome and related disorders J. Med. Genet., October 1, 2006; 43(10): 769 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. Suk, S. Jensen, A. McGettrick, A. C. Willis, P. Whiteman, C. Redfield, and P. A. Handford Structural Consequences of Cysteine Substitutions C1977Y and C1977R in Calcium-binding Epidermal Growth Factor-like Domain 30 of Human Fibrillin-1 J. Biol. Chem., December 3, 2004; 279(49): 51258 - 51265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Whiteman and P. A. Handford Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders Hum. Mol. Genet., April 1, 2003; 12(7): 727 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. McGettrick, V. Knott, A. Willis, and P. A. Handford Molecular effects of calcium binding mutations in Marfan syndrome depend on domain context Hum. Mol. Genet., August 12, 2000; 9(13): 1987 - 1994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. N Robinson and M. Godfrey The molecular genetics of Marfan syndrome and related microfibrillopathies J. Med. Genet., January 1, 2000; 37(1): 9 - 25. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Kuznetsov and S. K. Nigam Folding of Secretory and Membrane Proteins N. Engl. J. Med., December 3, 1998; 339(23): 1688 - 1695. [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Maron, J. H. Moller, C. E. Seidman, G. M. Vincent, H. C. Dietz, A. J. Moss, J. A. Towbin, H. M. Sondheimer, R. E. Pyeritz, G. McGee, et al. Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan Syndrome : A Statement for Healthcare Professionals From the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association Circulation, October 6, 1998; 98(14): 1460 - 1471. [Full Text] [PDF]
|
|
|
|
|
|
D. M. Milewicz, K. Michael, N. Fisher, J. S. Coselli, T. Markello, and A. Biddinger Fibrillin-1 (FBN1) Mutations in Patients With Thoracic Aortic Aneurysms Circulation, December 1, 1996; 94(11): 2708 - 2711. [Abstract] [Full Text]
|
|
|
|
 |
|
 L D Siracusa, R McGrath, Q Ma, J J Moskow, J Manne, P J Christner, A M Buchberg, and S A Jimenez A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res., April 1, 1996; 6(4): 300 - 313. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Kielty, T Rantamaki, A. Child, C. Shuttleworth, and L Peltonen Cysteine-to-arginine point mutation in a 'hybrid' eight-cysteine domain of FBN1: consequences for fibrillin aggregation and microfibril assembly J. Cell Sci., January 3, 1995; 108(3): 1317 - 1323. [Abstract] [PDF]
|
|
|
|
|
|
U. Francke and H. Furthmayr Marfan's Syndrome and Other Disorders of Fibrillin N. Engl. J. Med., May 12, 1994; 330(19): 1384 - 1385. [Full Text]
|
|